Patient-friendly summary
If you read nothing else
Bottom line
Pain neuroscience education appears to improve pain, disability, and psychosocial factors in chronic musculoskeletal pain with central sensitization, most reliably when combined with exercise or manual therapy and delivered one-to-one; long-term benefit and precise patient selection remain unproven.
Moderate evidencePublished
Evidence hierarchy
Study participants
Adults (≥18 years) with chronic musculoskeletal pain (≥3 months) due to central sensitization — including fibromyalgia, chronic fatigue syndrome, chronic spinal pain, and chronic low back pain
Full research — for clinicians and curious readers
Study Summary
This systematic review pooled 15 randomized controlled trials (1,085 participants) examining whether pain neuroscience education (PNE) — teaching patients about the biology and neurophysiology of pain — improves pain, disability, and psychosocial factors in people with chronic musculoskeletal pain driven by central sensitization. Because of high heterogeneity across studies, no meta-analysis was done; instead the authors synthesized results qualitatively, grouped by diagnosis (fibromyalgia, chronic fatigue syndrome, chronic spinal pain, and chronic low back pain). The authors conclude that PNE appears effective for improving these outcomes, especially when combined with other approaches such as therapeutic exercise or manual therapy, and when delivered in one-to-one oral sessions with reinforcement materials. They caution that most trials lacked specific eligibility criteria for central sensitization and that long-term effectiveness remains unknown.
Key Findings
| Finding | Detail | Impact |
|---|---|---|
| PNE appears effective for pain, disability, and psychosocial factors | Across the 15 included RCTs, the authors report PNE seems effective both as a stand-alone intervention and, more consistently, when delivered as part of a multidisciplinary program. PNE was not significantly superior to controls on all outcome measures in only two studies. | High |
| Combining PNE with active treatment works better than PNE alone, especially in chronic low back pain | In chronic low back pain, PNE plus therapeutic exercise outperformed exercise alone on kinesiophobia (TSK-11) and catastrophizing (PCS-13) at both follow-ups and on pain (NPRS) and disability (RMDQ) at 3 months. PNE added to manual therapy and home exercise also improved outcomes versus comparison groups. However, adding PNE to aquatic exercise or to usual physiotherapy did not add clear benefit. | High |
| Delivery format matters: one-to-one oral sessions with reinforcement seemed most effective | The authors conclude PNE was more effective when delivered through individual oral sessions with reinforcement elements (brochures, comprehension exercises) than through group, online, telephone, or content-only reading formats. | Medium |
| In fibromyalgia, benefit was tied to multidisciplinary delivery, not PNE as a stand-alone education | PNE added to usual fibromyalgia treatment outperformed usual care in two studies, but two other moderate-to-high-quality RCTs did not support PNE as a stand-alone intervention when compared with education-and-relaxation or self-management instruction. | Medium |
| Benefits in chronic spinal pain and chronic fatigue syndrome were limited to short-term follow-up | For chronic spinal pain, PNE improved catastrophizing and disability over neck/back school but only at short-term (2-week) follow-up. For chronic fatigue syndrome, a single moderate-quality RCT showed mixed psychosocial improvements measured only immediately post-session. | Medium |
| Most trials lacked specific central-sensitization eligibility criteria | Only two of the included studies explicitly defined their sample by central sensitization using CSI scores. For the remaining trials the reviewers manually screened baseline questionnaires (e.g., CSI, PCS, FABQ, TSK) to infer central-sensitization dominance, which the authors flag as a major limitation. | High |
Strengths
- First systematic review to focus specifically on PNE in chronic musculoskeletal pain with central sensitization.
- Followed PRISMA 2020 and registered the protocol prospectively with PROSPERO.
- Searched three databases (PubMed, PEDro, CINAHL) plus manual bibliography screening, with double-independent screening and risk-of-bias assessment.
- Good inter-rater agreement for full-text selection (Cohen's Kappa = 0.70).
- Transparent qualitative synthesis grouped by diagnostic label, reporting both between- and within-group results.
Limitations
- No meta-analysis was possible because of high heterogeneity in populations, interventions, comparators, outcomes, and follow-up timing.
- Only 2 of 15 included trials explicitly defined participants by central sensitization (CSI scores); the rest relied on the reviewers' manual screening of baseline questionnaires to infer central-sensitization dominance.
- Performance bias was rated high in all 15 studies (inherent difficulty of blinding in physical-therapy trials).
- Most follow-ups were short- or medium-term, so long-term effectiveness of PNE could not be assessed.
- Heterogeneous PNE delivery (dose, format, staff, content) and varied comparators limit the ability to pool results or define an optimal protocol.
- Eligibility limited to RCTs published in English or Italian, and effectiveness conclusions rest on a qualitative synthesis.
Key Takeaways for Patients
What This Means for You
Learning how pain works in the nervous system (pain neuroscience education) may help reduce pain, improve daily function, and lessen fear of movement and catastrophic thinking for people with long-standing musculoskeletal pain.
Education seems to work best as part of a broader plan — combined with exercise or hands-on therapy — rather than on its own.
One-to-one sessions with a trained clinician, supported by take-home materials like booklets, appeared more helpful than group, phone, or read-on-your-own formats.
Most of the benefit shown was short- to medium-term; it is not yet clear whether the improvements last long-term.
This review summarizes existing trials rather than testing a new treatment, and many of those trials did not precisely identify patients with central sensitization, so findings should be viewed as encouraging but not definitive.
Read the Full Paper
Access the complete peer-reviewed study from International Journal of Environmental Research and Public Health